Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03013283
Other study ID # RECHMPL16_0337
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 7, 2017
Est. completion date April 1, 2019

Study information

Verified date April 2019
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Home ventilation techniques consist mainly of two techniques, Continuous Positive Airway Pressure or CPAP and Non Invasive Ventilation or NIV. Whether for CPAP or NIV, pressures are delivered to the patient via an interface. The efficacy of CPAP and NIV is conditioned in part by the observance of the patients to the device. Because the comfort and degree of satisfaction of the patients to its interface is a key factor of the observance, side-effects and satisfaction of patients need to be continuously evaluated with available interfaces for CPAP and NIV treated patients. The purpose of the research is the evaluation of interface side-effects and the degree of satisfaction of home care patients treated for at least three months with CPAP or NIV.


Description:

Home ventilation techniques consist mainly of two techniques, Continuous Positive Airway Pressure or CPAP (the level of pressure delivered being constant) and Non Invasive Ventilation or NIV (pressure level varies from an expiratory pressure to an inspiratory pressure). Whether for CPAP or NIV, pressures are delivered to the patient via an interface. Many manufacturers produce interfaces and these interfaces are the subject of regular technological innovations with the introduction on the market of new product ranges. Because of the lack of dedicated and actualized studies, there is poor evidence based of difference between old and new interfaces, there is also poor evidence based of differences between manufacturer products. The efficacy of CPAP and NIV is conditioned in part by the observance of the patients to the device. Because the comfort and degree of satisfaction of the patients to its interface is a key factor of the observance, side-effects and satisfaction of patients need to be continuously evaluated with available interfaces for CPAP and NIV treated patients. The purpose of the research is the evaluation of interface side-effects and the degree of satisfaction of home care patients treated for at least three months with CPAP or NIV. A visual analog scale is used to assess the patient perception of its interface. A measure of the quality of life and a home care technician evaluation are performed simultaneously. Using the device manufacturer software, a measure of the observance, level of pressure and leak is realised. A first intermediate analysis will be made after approximately 1000 inclusions (the Sleepileaks (determinants of residual excessive sleapiness), Threshleaks (high leak levels and machine adherence as defined by the American Thoracic Society) and Complileaks studies (all leaks and machine adherence as continuous variables)). A second validating analysis will be made at the end of inclusions.


Recruitment information / eligibility

Status Completed
Enrollment 6000
Est. completion date April 1, 2019
Est. primary completion date April 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Written informed consent - Age more than 18 years (inclusive) - Patient treated with CPAP or NIV for at least three months,and eligible for care and for the reimbursement by the French Social Security rules. - Patient presents during a scheduled home visit of the technician for the continuation of CPAP or NIV treatment according to the French Social Security rules. Exclusion Criteria: - Pregnancy, intention of being pregnant, breastfeeding. - Inability to understand the nature and aims of the study or to communicate with the investigator - Simultaneous participation in another trial with an exclusion clause to participate to an other trial. - No affiliation to the French social security - Loss of personal capacity resulting in state protection - Deprivation of liberty by judicial or administrative decision

Study Design


Intervention

Other:
self questionnaire
Interface side effects and degree of satisfaction of the patients Technician evaluation and device measures.

Locations

Country Name City State
France Centre Hospitalier Universitaire de Montpellier Montpellier
France CHU Saint-Etienne Saint-Etienne

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

References & Publications (2)

Rotty MC, Mallet JP, Suehs CM, Martinez C, Borel JC, Rabec C, Bourdin A, Molinari N, Jaffuel D. Is the 2013 American Thoracic Society CPAP-tracking system algorithm useful for managing non-adherence in long-term CPAP-treated patients? Respir Res. 2019 Sep — View Citation

Rotty MC, Suehs CM, Mallet JP, Martinez C, Borel JC, Rabec C, Bertelli F, Bourdin A, Molinari N, Jaffuel D. Mask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life study. Respir Res. 2021 Jan 15;22(1):17. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Interface side effects and degree of satisfaction of the patients During a scheduled home visit of the technician. The primary endpoint is a composite criterion corresponding to the patients' responses to a self-administered questionnaire. 1 day
Secondary Identification by the technician of the problems of pain During a scheduled home visit of the technician : Identification by the technician of the problems of pain, erythema and leak, localization of these problems. 1 day
Secondary Percentage of patients with oxygen therapy, heated humidifier, chinstrap. During a scheduled home visit of the technician : Percentage of patients with oxygen therapy, heated humidifier, chinstrap. 1 day
Secondary Collection by technician of the type of interface During a scheduled home visit of the technician : Collection by technician of the type of interface (nasal pillows, nasal and oronasal, custom made interface), manufacturer name and interface size, type (CPAP/NIV) and manufacturer name of the device. 1 day
Secondary Compliance During a scheduled home visit of the technician : Device software data: compliance (hour per day) over the last 3 months 1 day
Secondary Average level of intentional or unintentional leakage During a scheduled home visit of the technician : Device software data: average level of intentional or unintentional leakage (l/min) 1 day
Secondary Residual AHI During a scheduled home visit of the technician : Device software data: residual AHI (event/hour) 1 day
Secondary Average pressure level and pressure During a scheduled home visit of the technician :Device software data: average pressure level and pressure at the 90/95th percentile (cmH2O). 1 day
Secondary Patient quality of life questionnaire Patient quality of life questionnaire (EQ-5D 3L, Epworth). 1 day
Secondary Date of first installation of the first ventilation device Date of first installation of the first ventilation device 1 day
Secondary Proportion of patient responding to self-help questionnaire without assistance Proportion of patient responding to self-help questionnaire without assistance 1 day
Secondary Proportion of patients able to position the interface without assistance Proportion of patients able to position the interface without assistance 1 day
Secondary Time taken by the patient and the technician to answer the patient's self-questionnaire and the technician record respectively. Time taken by the patient and the technician to answer the patient's self-questionnaire and the technician record respectively. 1 day
Secondary Proportion of patient waiting for a new interface Proportion of patient waiting for a new interface 1 day
Secondary Proportion of patients wishing to participate in research on the subject. Proportion of patients wishing to participate in research on the subject. 1 day